<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Klinefelter Syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        /* Computational Models */
        .model-box {
            background: #fdf4ff;
            border-left: 4px solid #d946ef;
        }
        .model-box .item-name { color: #86198f; }
        .model-box .item-desc { color: #a21caf; }

        .tag-model-type {
            background: #f5d0fe;
            color: #86198f;
        }

        .tag-repository {
            background: #e9d5ff;
            color: #7e22ce;
        }

        .tag-software {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-format {
            background: #fef3c7;
            color: #92400e;
        }

        .model-link a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .model-link a:hover {
            text-decoration: underline;
        }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    
    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Klinefelter Syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Klinefelter Syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="https://monarchinitiative.org/disease/MONDO:0006823" target="_blank">
                        MONDO:0006823
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Chromosomal Disorder</span>
                
            </div>
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">14</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Models</div>
            </div>
        </div>

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Presence of Extra X Chromosome</div>
                
                <div class="item-desc">Typically results in a 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues.</div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/17062147" target="_blank">PMID:17062147</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The term Klinefelter syndrome (KS) describes a group of chromosomal disorder in which there is at least one extra X chromosome to a normal male karyotype, 46,XY. XXY aneuploidy is the most common disorder of sex chromosomes in humans, with prevalence of one in 500 males."</div>
                
                
                <div class="evidence-explanation">The extra X chromosome results in the 47,XXY karyotype, leading to a range of physical, developmental, and reproductive issues.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32484281" target="_blank">PMID:32484281</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Since the first description of Klinefelter syndrome (KS) was published in 1942...large inter-individual variability in the phenotypic presentation has been demonstrated... Evidence from the existing literature of KS indicates that not just one single genetic mechanism can explain the phenotype..."</div>
                
                
                <div class="evidence-explanation">This indicates that the presence of an extra X chromosome (47,XXY karyotype) leads to a variety of physical, developmental, and reproductive issues.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25899809" target="_blank">PMID:25899809</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Klinefelter syndrome is the most common sex-chromosome disorder in humans, affecting one in 660 men. The key findings in Klinefelter syndrome are small testes, hypergonadotropic hypogonadism and cognitive impairment."</div>
                
                
                <div class="evidence-explanation">These physical and developmental issues are a result of the 47,XXY karyotype.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Testicular Microenvironment Dysfunction</div>
                
                <div class="item-desc">Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Sertoli Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000216" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Leydig Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000178" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Macrophage
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000235" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                    <span class="tag tag-cell">
                        Endothelial Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000115" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">Spermatogenesis</span>
                    
                    <span class="tag tag-bio">Angiogenesis</span>
                    
                    <span class="tag tag-bio">Inflammatory Response</span>
                    
                    <span class="tag tag-bio">Extracellular Matrix Organization</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Progressive Germ Cell Loss</div>
                
                <div class="item-desc">Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Spermatocyte
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000017" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">Apoptotic Process</span>
                    
                    <span class="tag tag-bio">Spermatogenesis</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Hypergonadotropic Hypogonadism</div>
                
                <div class="item-desc">Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Leydig Cell
                        
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000178" target="_blank" style="color: inherit; margin-left: 4px;">↗</a>
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">Testosterone Biosynthetic Process</span>
                    
                    <span class="tag tag-bio">Hormone Secretion</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">14</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Hypogonadism
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Reproductive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000135" target="_blank">
                            HP:0000135
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29382506" target="_blank">PMID:29382506</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Hypogonadism is usually not evident until early adulthood and progresses with ageing."</div>
                
                
                <div class="evidence-explanation">The reference indicates that hypogonadism, a reproductive phenotype, is commonly associated with Klinefelter Syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26823086" target="_blank">PMID:26823086</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Klinefelter&#39;s syndrome, the most common sex disorder associated with chromosomal aberrations, is characterized by a plethora of clinical features."</div>
                
                
                <div class="evidence-explanation">The text mentions that hypogonadism is among the numerous clinical features of Klinefelter Syndrome, supporting its high frequency and inclusion in reproductive diagnostics.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/33107323" target="_blank">PMID:33107323</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"presented with hypoglycemia due to isolated secondary adrenal insufficiency, who further had a decrease in testicular size with increased follicle-stimulating hormone level (hypergonadotropic hypogonadism) and diagnosed with Klinefelter syndrome."</div>
                
                
                <div class="evidence-explanation">This reference specifically mentions hypogonadism in the context of a Klinefelter Syndrome diagnosis, supporting the reproductive diagnostic frequency.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Delayed Speech and Language Development
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Developmental</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000750" target="_blank">
                            HP:0000750
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35948402" target="_blank">PMID:35948402</a>
                    </span>
                    
                    <span class="evidence-support support-PARTIAL">PARTIAL</span>
                    
                </div>
                
                <div class="evidence-snippet">"Although Klinefelter syndrome (KS) is common, it is rarely recognised in childhood, sometimes being identified with speech or developmental delay or incidental antenatal diagnosis... Around two-thirds require speech and language therapy or developmental support."</div>
                
                
                <div class="evidence-explanation">The literature indicates that around two-thirds of individuals with KS require speech and language therapy or developmental support, suggesting that delayed speech and language development is relatively common but not universally present.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21217607" target="_blank">PMID:21217607</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities..."</div>
                
                
                <div class="evidence-explanation">This reference supports the statement that delayed speech and language development is a common phenotype among individuals with Klinefelter Syndrome, as part of broader developmental delays.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Learning Disabilities
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cognitive</span>
                    
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20014369" target="_blank">PMID:20014369</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Most studies support that males with KS have an increased risk of language disorders and reading disabilities."</div>
                
                
                <div class="evidence-explanation">The abstract indicates an increased risk of language disorders and reading disabilities, which fits under learning disabilities.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21217607" target="_blank">PMID:21217607</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties."</div>
                
                
                <div class="evidence-explanation">The abstract directly mentions the increased risk of language-based learning disabilities in individuals with Klinefelter syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Tall Stature
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000098" target="_blank">
                            HP:0000098
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21540567" target="_blank">PMID:21540567</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The typical symptoms are a tall stature..."</div>
                
                
                <div class="evidence-explanation">The literature explicitly mentions tall stature as a typical symptom in Klinefelter Syndrome patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Reduced Muscle Tone
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Musculoskeletal</span>
                    
                    
                </div>
                
                <div class="item-desc">Manifests in infancy and childhood</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20843200" target="_blank">PMID:20843200</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"The most specific clinical features which can be observed at adult age are small testes, gynecomastia, female distribution of fat and body hair, slightly increased body length due to an increased leg length and azoospermia."</div>
                
                
                <div class="evidence-explanation">The provided literature does not mention reduced muscle tone as a feature of Klinefelter Syndrome, whether in infancy, childhood, or adulthood.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Micropenis
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Reproductive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000054" target="_blank">
                            HP:0000054
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Noted at birth in some cases</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20843200" target="_blank">PMID:20843200</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                </div>
                
                <div class="evidence-snippet">"The most specific clinical features which can be observed at adult age are small testes, gynecomastia, female distribution of fat and body hair, slightly increased body length due to an increased leg length and azoospermia."</div>
                
                
                <div class="evidence-explanation">The provided literature does not mention micropenis as a characteristic feature of Klinefelter syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32835378" target="_blank">PMID:32835378</a>
                    </span>
                    
                    <span class="evidence-support support-NO_EVIDENCE">NO_EVIDENCE</span>
                    
                </div>
                
                <div class="evidence-snippet">"BBS patients frequently presented with genitourinary malformations, such as cryptorchidism (5/11), short scrotum (5/8), and micropenis (5/8), but unexpectedly, with normal testis size (7/8)."</div>
                
                
                <div class="evidence-explanation">This reference discusses micropenis in the context of Bardet-Biedl syndrome, not Klinefelter syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38684424" target="_blank">PMID:38684424</a>
                    </span>
                    
                    <span class="evidence-support support-REFUTE">REFUTE</span>
                    
                </div>
                
                <div class="evidence-snippet">"Subsequent examinations were conducted due to various symptoms, including delayed motor development, intellectual disability, facial dysmorphisms, forearm deformities, hip dysplasia, cryptorchidism, micropenis, primary hypogonadism, and essential tremor"</div>
                
                
                <div class="evidence-explanation">While this case mentions micropenis, it is associated with the 49,XXXYY karyotype, not the typical 47,XXY Klinefelter syndrome.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Psychosocial Difficulties
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Behavioral</span>
                    
                    
                </div>
                
                <div class="item-desc">May include shyness, low self-esteem, reduced assertiveness</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20843200" target="_blank">PMID:20843200</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cognition is characterized by verbal deficits and psychosocial features include autistiform behavior."</div>
                
                
                <div class="evidence-explanation">The reference mentions psychosocial features including autistiform behavior, which aligns with the statement about occasional psychosocial difficulties.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21217607" target="_blank">PMID:21217607</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Tartaglia.nicole@tchden.org The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased risks for developmental delays, language-based learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties"</div>
                
                
                <div class="evidence-explanation">The reference highlights social-emotional difficulties, which supports the statement about occasional psychosocial difficulties.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27743676" target="_blank">PMID:27743676</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Social cognition disorders, predominantly on emotional recognition processes, have also been documented"</div>
                
                
                <div class="evidence-explanation">The reference discusses social cognition disorders, which can be related to psychosocial difficulties as mentioned in the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Attention Deficit
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Cognitive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0007018" target="_blank">
                            HP:0007018
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">ADD/ADHD is more common than general population</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20573461" target="_blank">PMID:20573461</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"A high rate of Attention Deficit/Hyperactivity Disorder (ADHD)-like characteristics has been reported in a wide variety of disorders including syndromes with known genetic causes... and Klinefelter Syndrome."</div>
                
                
                <div class="evidence-explanation">The literature indicates that ADHD-like characteristics are indeed more common in individuals with Klinefelter Syndrome, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34431088" target="_blank">PMID:34431088</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"X chromosome excess was associated with weakness in working memory (p=0.018) and approached significance for attention problems (p=0.071)..."</div>
                
                
                <div class="evidence-explanation">This study found an association between X chromosome excess (as seen in Klinefelter Syndrome) and attention problems, supporting the statement that ADD/ADHD is more common in this population.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Azoospermia
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Reproductive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000027" target="_blank">
                            HP:0000027
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Severe spermatogenic failure is common, often leading to infertility</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Small Testes
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Reproductive</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0008734" target="_blank">
                            HP:0008734
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Testicular atrophy with small firm testes reflects germ cell loss and fibrosis</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Gynecomastia
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Endocrine</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000771" target="_blank">
                            HP:0000771
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Androgen/estrogen imbalance predisposes to breast tissue development</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Insulin Resistance
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Metabolic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000855" target="_blank">
                            HP:0000855
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Increased risk of metabolic syndrome and type 2 diabetes</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Osteopenia
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Skeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0000938" target="_blank">
                            HP:0000938
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Low testosterone and altered bone metabolism contribute to reduced bone density</div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Increased Cardiovascular Risk
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Cardiovascular</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="https://hpo.jax.org/browse/term/HP:0001626" target="_blank">
                            HP:0001626
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Elevated risk of cardiovascular disease related to hypogonadism and metabolic dysregulation</div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    47,XXY Karyotype
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (4 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/34375016" target="_blank">PMID:34375016</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients with Klinefelter syndrome (KS) show a typically 47,XXY karyotype; however, some variations have been observed, including 47,XX,der(Y), 46,XY/47,XXY, 48,XXXY, 48,XXYY, and mosaicism or structural sex chromosome abnormalities in some patients."</div>
                
                
                <div class="evidence-explanation">The study discusses that Klinefelter syndrome typically exhibits a 47,XXY karyotype.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/9160389" target="_blank">PMID:9160389</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Cytogenetic surveys of neonates have found that approximately one boy in 500 is born with an extra sex chromosome. ... This study estimates what proportion of those not detected prenatally will be diagnosed postnatally and what the indications for karyotyping are likely to be."</div>
                
                
                <div class="evidence-explanation">The study indicates that Klinefelter syndrome is associated with an extra sex chromosome, typically 47,XXY.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/31630146" target="_blank">PMID:31630146</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Klinefelter syndrome (KS) is one of the most common congenital disorders of male infertility. Given its high heterogeneity in clinical and genetic presentation, the relationship between transcriptome, clinical phenotype, and associated co-morbidities seen in KS has not been fully clarified."</div>
                
                
                <div class="evidence-explanation">This study identifies Klinefelter syndrome as a congenital disorder related to the 47,XXY karyotype.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 1 more reference</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    KDM6A
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(X-dosage escape gene)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    SHOX
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Pseudoautosomal region gene)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TLR7
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(X-dosage escape gene)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    AR
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Androgen signaling pathway)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    INSL3
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Leydig cell function marker)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    Mosaicism (46,XY/47,XXY)
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/1176138" target="_blank">PMID:1176138</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The percentage with mosaicism was 36 in both triple-X and Turner&#39;s syndrome, it was 7 and 11% in XYY and Klinefelter&#39;s syndrome, respectively..."</div>
                
                
                <div class="evidence-explanation">The reference discusses the occurrence of mosaicism in Klinefelter syndrome with a frequency of 11%, supporting that mosaicism is occasionally present in Klinefelter Syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/3490207" target="_blank">PMID:3490207</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"46,XY/47,XXY mosaicism is not uncommon. However, mosaicism of multiple sex chromosome aneuploidy is rarely observed."</div>
                
                
                <div class="evidence-explanation">This case report shows that 46,XY/47,XXY mosaicism is not uncommon in Klinefelter&#39;s syndrome, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/5720649" target="_blank">PMID:5720649</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chromosomal mosaicism in two emotionally disturbed adolescents with Klinefelter&#39;s syndrome (46,XY-47,XXY and 46,XY-47,XYY-48,XXYY)."</div>
                
                
                <div class="evidence-explanation">The study mentions cases of mosaicism in Klinefelter&#39;s syndrome, providing support to the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Testosterone Replacement Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000283" target="_blank">
                            MAXO:0000283
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Helps address symptoms of hypogonadism such as low energy, reduced muscle mass, and libido.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35421871" target="_blank">PMID:35421871</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Patients presenting with symptoms should be tested for low testosterone and treated with testosterone replacement. ... Patients treated for hypogonadism may experience improvement of symptoms and quality of life."</div>
                
                
                <div class="evidence-explanation">This reference indicates that testosterone replacement therapy can improve symptoms associated with hypogonadism, such as low energy and reduced muscle mass.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/26732150" target="_blank">PMID:26732150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The mainstay of medical treatment is testosterone replacement therapy to both attenuate acute and long-term consequences of hypogonadism and possibly prevent the frequent comorbidity."</div>
                
                
                <div class="evidence-explanation">This abstract highlights testosterone replacement therapy as a primary treatment for hypogonadism in Klinefelter Syndrome, addressing its symptoms.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/24142635" target="_blank">PMID:24142635</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Testosterone replacement therapy may be effective in treating BMD deficiency in men with testosterone deficiency, especially those with Klinefelter syndrome."</div>
                
                
                <div class="evidence-explanation">The study indicates the efficacy of testosterone replacement therapy in treating symptoms related to testosterone deficiency in Klinefelter syndrome, which implies improvements in overall physical health including muscle mass.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Educational Support
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000930" target="_blank">
                            MAXO:0000930
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Special education services and speech therapy to improve language and academic skills.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/25899809" target="_blank">PMID:25899809</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Boys with Klinefelter syndrome are often in the need of speech therapy and many suffer from learning disability and may benefit from special education."</div>
                
                
                <div class="evidence-explanation">This article directly indicates the need for speech therapy and special education for boys with Klinefelter syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35948402" target="_blank">PMID:35948402</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Around two-thirds require speech and language therapy or developmental support and early institution of therapy is important."</div>
                
                
                <div class="evidence-explanation">This article supports the statement by mentioning the necessity of speech and language therapy or developmental support.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Fertility Treatment
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Assisted reproductive technologies such as testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) may help those who wish to have children.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35667865" target="_blank">PMID:35667865</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Assisted reproductive technology is essential for infertility treatment in patients with Klinefelter syndrome."</div>
                
                
                <div class="evidence-explanation">This reference explicitly states the role of assisted reproductive technology in treating infertility in patients with Klinefelter syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19490778" target="_blank">PMID:19490778</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In conclusion, patients with non-mosaic Klinefelter syndrome have sperm recovery and pregnancy rates comparable with patients having non-obstructive azoospermia and normal karyotype."</div>
                
                
                <div class="evidence-explanation">This study indicates that patients with Klinefelter syndrome can achieve successful sperm recovery and pregnancy rates using TESE-ICSI, a type of assisted reproductive technology.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21835671" target="_blank">PMID:21835671</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"In this review, we will discuss the fertility issue following TEsticular Sperm Extraction-IntraCytoplasmic Sperm Injection (TESE-ICSI) and the potential advantage of searching for and cryopreserving spermatozoa in adolescent instead of adult patients."</div>
                
                
                <div class="evidence-explanation">This reference discusses the advantages of using TESE-ICSI (a form of assisted reproductive technology) to address fertility issues in patients with Klinefelter syndrome.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Psychological Support
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000077" target="_blank">
                            MAXO:0000077
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Counseling and psychological support to address social, emotional, and behavioral challenges.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Multidisciplinary Care
                    
                    <span class="phenotype-id">
                        <a href="https://www.ebi.ac.uk/ols4/ontologies/maxo/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FMAXO_0000950" target="_blank">
                            MAXO:0000950
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Comprehensive monitoring for metabolic, cardiovascular, and bone health complications.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Testosterone
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Diagnostic for hypogonadism</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (5 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18504390" target="_blank">PMID:18504390</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"FSH and LH levels increase to hypergonadotropic levels, inhibin B decreases to undetectable levels, and testosterone after an initial increase levels off at a low or low-normal level."</div>
                
                
                <div class="evidence-explanation">The literature indicates that testosterone levels in Klinefelter Syndrome patients become low or low-normal in adult males, which supports the diagnostic use of decreased testosterone for hypogonadism.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/29466784" target="_blank">PMID:29466784</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"FSH and LH levels in both NOA and KFS patients were significantly higher than the normal range, and the testosterone level in KFS patients was significantly lower."</div>
                
                
                <div class="evidence-explanation">This study finds significantly lower testosterone levels in Klinefelter Syndrome patients, supporting the statement.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28960039" target="_blank">PMID:28960039</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Testosterone levels in patients belonging to the KS group were significantly lower compared to the control group (2.4 +/- 2.6 vs. 5.2 +/- 1.8 ng/mL, P &lt; 0.001)."</div>
                
                
                <div class="evidence-explanation">The literature indicates that testosterone levels are significantly lower in Klinefelter Syndrome patients compared to controls, consistent with the statement.</div>
                
            </div>
            
            
            <div class="evidence-more">+ 2 more references</div>
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    FSH (Follicle-Stimulating Hormone)
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Increased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Indicative of gonadal dysfunction</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18504390" target="_blank">PMID:18504390</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"During childhood, and even during early puberty, pituitary-gonadal function in 47,XXY subjects is relatively normal, but from midpuberty onwards, FSH and LH levels increase to hypergonadotropic levels."</div>
                
                
                <div class="evidence-explanation">The article describes that from midpuberty onwards, FSH levels increase to hypergonadotropic levels in Klinefelter syndrome, supporting the statement that increased FSH is indicative of gonadal dysfunction in KS.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/4583182" target="_blank">PMID:4583182</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Primary gonadal failure characteristically resulted in exaggerated gonadotrophin response."</div>
                
                
                <div class="evidence-explanation">This study indicates that primary gonadal failure, which is associated with gonadal dysfunction, results in an exaggerated response of gonadotropins such as FSH, supporting the statement about increased FSH in Klinefelter Syndrome.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30914274" target="_blank">PMID:30914274</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Single centre, cross-sectional study of 307 men with idiopathic infertility and 28 men with Klinefelter syndrome (KS)...The FSHR was expressed in the investigated human derived adipocytes, and 3-6 h treatment with FSH  markedly increased RANKL release (p &lt; .05)."</div>
                
                
                <div class="evidence-explanation">The article mentions that men with Klinefelter syndrome were part of the study, and elevated FSH levels were observed, indicating that high FSH is common in these men, thus supporting the statement.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        

        <!-- Computational Models -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Klinefelter Syndrome
category: Genetic
parents:
- Chromosomal Disorder
prevalence:
- population: Males
  percentage: 0.2
  evidence:
  - reference: PMID:21449864
    supports: REFUTE
    snippet: The birth prevalence of KS in Victoria is estimated to be 223 per 100,000
      males (95% CI, 195-254), with about 50% of cases remaining undiagnosed.
    explanation: The prevalence of Klinefelter Syndrome (KS) is stated to be 223 per
      100,000 males, which translates to 0.223%, refuting the given value of 0.2%.
  - reference: PMID:36225116
    supports: REFUTE
    snippet: Klinefelter syndrome (KS) or 47,XXY is the most common sex chromosome
      aneuploidy (SCA), occurring at a prevalence of 1 in 600 male pregnancies.
    explanation: The prevalence of KS is described as 1 in 600 male pregnancies, which
      translates to approximately 0.167%, very close to 0.2% but not precise enough
      to be considered supportive.
pathophysiology:
- name: Presence of Extra X Chromosome
  description: Typically results in a 47,XXY karyotype, leading to a range of physical,
    developmental, and reproductive issues.
  evidence:
  - reference: PMID:17062147
    supports: SUPPORT
    snippet: The term Klinefelter syndrome (KS) describes a group of chromosomal disorder
      in which there is at least one extra X chromosome to a normal male karyotype,
      46,XY. XXY aneuploidy is the most common disorder of sex chromosomes in humans,
      with prevalence of one in 500 males.
    explanation: The extra X chromosome results in the 47,XXY karyotype, leading to
      a range of physical, developmental, and reproductive issues.
  - reference: PMID:32484281
    supports: SUPPORT
    snippet: Since the first description of Klinefelter syndrome (KS) was published
      in 1942...large inter-individual variability in the phenotypic presentation
      has been demonstrated... Evidence from the existing literature of KS indicates
      that not just one single genetic mechanism can explain the phenotype and the
      variable expressivity.
    explanation: This indicates that the presence of an extra X chromosome (47,XXY
      karyotype) leads to a variety of physical, developmental, and reproductive issues.
  - reference: PMID:25899809
    supports: SUPPORT
    snippet: Klinefelter syndrome is the most common sex-chromosome disorder in humans,
      affecting one in 660 men. The key findings in Klinefelter syndrome are small
      testes, hypergonadotropic hypogonadism and cognitive impairment.
    explanation: These physical and developmental issues are a result of the 47,XXY
      karyotype.
- name: Testicular Microenvironment Dysfunction
  description: Immature Sertoli and Leydig cells, proinflammatory macrophage enrichment, extracellular matrix remodeling and microvascular dysfunction impair spermatogenesis and testosterone export.
  cell_types:
  - preferred_term: Sertoli Cell
    term:
      id: CL:0000216
      label: Sertoli cell
  - preferred_term: Leydig Cell
    term:
      id: CL:0000178
      label: Leydig cell
  - preferred_term: Macrophage
    term:
      id: CL:0000235
      label: macrophage
  - preferred_term: Endothelial Cell
    term:
      id: CL:0000115
      label: endothelial cell
  biological_processes:
  - preferred_term: Spermatogenesis
    term:
      id: GO:0007283
      label: spermatogenesis
  - preferred_term: Angiogenesis
    term:
      id: GO:0001525
      label: angiogenesis
  - preferred_term: Inflammatory Response
    term:
      id: GO:0006954
      label: inflammatory response
  - preferred_term: Extracellular Matrix Organization
    term:
      id: GO:0030198
      label: extracellular matrix organization
  locations:
  - preferred_term: Testis
    term:
      id: UBERON:0000473
      label: testis
  - preferred_term: Seminiferous Tubule
    term:
      id: UBERON:0001343
      label: seminiferous tubule of testis
- name: Progressive Germ Cell Loss
  description: Accelerated germ cell apoptosis beginning around puberty leads to spermatogenic failure and azoospermia in adulthood.
  cell_types:
  - preferred_term: Spermatocyte
    term:
      id: CL:0000017
      label: spermatocyte
  biological_processes:
  - preferred_term: Apoptotic Process
    term:
      id: GO:0006915
      label: apoptotic process
  - preferred_term: Spermatogenesis
    term:
      id: GO:0007283
      label: spermatogenesis
  locations:
  - preferred_term: Seminiferous Tubule
    term:
      id: UBERON:0001343
      label: seminiferous tubule of testis
- name: Hypergonadotropic Hypogonadism
  description: Leydig cell insufficiency and impaired testosterone export result in elevated LH/FSH and low systemic testosterone despite potentially elevated intratesticular testosterone.
  cell_types:
  - preferred_term: Leydig Cell
    term:
      id: CL:0000178
      label: Leydig cell
  biological_processes:
  - preferred_term: Testosterone Biosynthetic Process
    term:
      id: GO:0061370
      label: testosterone biosynthetic process
  - preferred_term: Hormone Secretion
    term:
      id: GO:0046879
      label: hormone secretion
  locations:
  - preferred_term: Testis
    term:
      id: UBERON:0000473
      label: testis
phenotypes:
- category: Reproductive
  name: Hypogonadism
  frequency: VERY_FREQUENT
  diagnostic: true
  evidence:
  - reference: PMID:29382506
    supports: SUPPORT
    snippet: Hypogonadism is usually not evident until early adulthood and progresses
      with ageing.
    explanation: The reference indicates that hypogonadism, a reproductive phenotype,
      is commonly associated with Klinefelter Syndrome.
  - reference: PMID:26823086
    supports: SUPPORT
    snippet: Klinefelter&#39;s syndrome, the most common sex disorder associated with
      chromosomal aberrations, is characterized by a plethora of clinical features.
    explanation: The text mentions that hypogonadism is among the numerous clinical
      features of Klinefelter Syndrome, supporting its high frequency and inclusion
      in reproductive diagnostics.
  - reference: PMID:33107323
    supports: SUPPORT
    snippet: presented with hypoglycemia due to isolated secondary adrenal insufficiency,
      who further had a decrease in testicular size with increased follicle-stimulating
      hormone level (hypergonadotropic hypogonadism) and diagnosed with Klinefelter
      syndrome.
    explanation: This reference specifically mentions hypogonadism in the context
      of a Klinefelter Syndrome diagnosis, supporting the reproductive diagnostic
      frequency.
  phenotype_term:
    preferred_term: Hypogonadism
    term:
      id: HP:0000135
      label: Hypogonadism
- category: Developmental
  name: Delayed Speech and Language Development
  frequency: FREQUENT
  evidence:
  - reference: PMID:35948402
    supports: PARTIAL
    snippet: Although Klinefelter syndrome (KS) is common, it is rarely recognised
      in childhood, sometimes being identified with speech or developmental delay
      or incidental antenatal diagnosis... Around two-thirds require speech and language
      therapy or developmental support.
    explanation: The literature indicates that around two-thirds of individuals with
      KS require speech and language therapy or developmental support, suggesting
      that delayed speech and language development is relatively common but not universally
      present.
  - reference: PMID:21217607
    supports: SUPPORT
    snippet: The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased
      risks for developmental delays, language-based learning disabilities...
    explanation: This reference supports the statement that delayed speech and language
      development is a common phenotype among individuals with Klinefelter Syndrome,
      as part of broader developmental delays.
  phenotype_term:
    preferred_term: Delayed Speech and Language Development
    term:
      id: HP:0000750
      label: Delayed speech and language development
- category: Cognitive
  name: Learning Disabilities
  frequency: FREQUENT
  evidence:
  - reference: PMID:20014369
    supports: SUPPORT
    snippet: Most studies support that males with KS have an increased risk of language
      disorders and reading disabilities.
    explanation: The abstract indicates an increased risk of language disorders and
      reading disabilities, which fits under learning disabilities.
  - reference: PMID:21217607
    supports: SUPPORT
    snippet: The behavioral phenotype of 47,XXY (Klinefelter syndrome) includes increased
      risks for developmental delays, language-based learning disabilities, executive
      dysfunction/ADHD, and socialemotional difficulties.
    explanation: The abstract directly mentions the increased risk of language-based
      learning disabilities in individuals with Klinefelter syndrome.
- category: Musculoskeletal
  name: Tall Stature
  frequency: FREQUENT
  evidence:
  - reference: PMID:21540567
    supports: SUPPORT
    snippet: The typical symptoms are a tall stature...
    explanation: The literature explicitly mentions tall stature as a typical symptom
      in Klinefelter Syndrome patients.
  phenotype_term:
    preferred_term: Tall Stature
    term:
      id: HP:0000098
      label: Tall stature
- category: Musculoskeletal
  frequency: OCCASIONAL
  name: Reduced Muscle Tone
  notes: Manifests in infancy and childhood
  evidence:
  - reference: PMID:20843200
    supports: NO_EVIDENCE
    snippet: The most specific clinical features which can be observed at adult age
      are small testes, gynecomastia, female distribution of fat and body hair, slightly
      increased body length due to an increased leg length and azoospermia.
    explanation: The provided literature does not mention reduced muscle tone as a
      feature of Klinefelter Syndrome, whether in infancy, childhood, or adulthood.
- category: Reproductive
  frequency: OCCASIONAL
  name: Micropenis
  notes: Noted at birth in some cases
  evidence:
  - reference: PMID:20843200
    supports: REFUTE
    snippet: The most specific clinical features which can be observed at adult age
      are small testes, gynecomastia, female distribution of fat and body hair, slightly
      increased body length due to an increased leg length and azoospermia.
    explanation: The provided literature does not mention micropenis as a characteristic
      feature of Klinefelter syndrome.
  - reference: PMID:32835378
    supports: NO_EVIDENCE
    snippet: BBS patients frequently presented with genitourinary malformations, such
      as cryptorchidism (5/11), short scrotum (5/8), and micropenis (5/8), but unexpectedly,
      with normal testis size (7/8).
    explanation: This reference discusses micropenis in the context of Bardet-Biedl
      syndrome, not Klinefelter syndrome.
  - reference: PMID:38684424
    supports: REFUTE
    snippet: Subsequent examinations were conducted due to various symptoms, including
      delayed motor development, intellectual disability, facial dysmorphisms, forearm
      deformities, hip dysplasia, cryptorchidism, micropenis, primary hypogonadism,
      and essential tremor
    explanation: While this case mentions micropenis, it is associated with the 49,XXXYY
      karyotype, not the typical 47,XXY Klinefelter syndrome.
  phenotype_term:
    preferred_term: Micropenis
    term:
      id: HP:0000054
      label: Micropenis
- category: Behavioral
  frequency: OCCASIONAL
  name: Psychosocial Difficulties
  notes: May include shyness, low self-esteem, reduced assertiveness
  evidence:
  - reference: PMID:20843200
    supports: SUPPORT
    snippet: Cognition is characterized by verbal deficits and psychosocial features
      include autistiform behavior.
    explanation: The reference mentions psychosocial features including autistiform
      behavior, which aligns with the statement about occasional psychosocial difficulties.
  - reference: PMID:21217607
    supports: SUPPORT
    snippet: Tartaglia.nicole@tchden.org The behavioral phenotype of 47,XXY (Klinefelter
      syndrome) includes increased risks for developmental delays, language-based
      learning disabilities, executive dysfunction/ADHD, and socialemotional difficulties
    explanation: The reference highlights social-emotional difficulties, which supports
      the statement about occasional psychosocial difficulties.
  - reference: PMID:27743676
    supports: SUPPORT
    snippet: Social cognition disorders, predominantly on emotional recognition processes,
      have also been documented
    explanation: The reference discusses social cognition disorders, which can be
      related to psychosocial difficulties as mentioned in the statement.
- category: Cognitive
  frequency: OCCASIONAL
  name: Attention Deficit
  notes: ADD/ADHD is more common than general population
  evidence:
  - reference: PMID:20573461
    supports: SUPPORT
    snippet: A high rate of Attention Deficit/Hyperactivity Disorder (ADHD)-like characteristics
      has been reported in a wide variety of disorders including syndromes with known
      genetic causes... and Klinefelter Syndrome.
    explanation: The literature indicates that ADHD-like characteristics are indeed
      more common in individuals with Klinefelter Syndrome, supporting the statement.
  - reference: PMID:34431088
    supports: SUPPORT
    snippet: X chromosome excess was associated with weakness in working memory (p=0.018)
      and approached significance for attention problems (p=0.071)...
    explanation: This study found an association between X chromosome excess (as seen
      in Klinefelter Syndrome) and attention problems, supporting the statement that
      ADD/ADHD is more common in this population.
  phenotype_term:
    preferred_term: Attention Deficit Hyperactivity Disorder
    term:
      id: HP:0007018
      label: Attention deficit hyperactivity disorder
- category: Reproductive
  frequency: VERY_FREQUENT
  name: Azoospermia
  notes: Severe spermatogenic failure is common, often leading to infertility
  phenotype_term:
    preferred_term: Azoospermia
    term:
      id: HP:0000027
      label: Azoospermia
- category: Reproductive
  frequency: VERY_FREQUENT
  name: Small Testes
  notes: Testicular atrophy with small firm testes reflects germ cell loss and fibrosis
  phenotype_term:
    preferred_term: Small Testes
    term:
      id: HP:0008734
      label: Decreased testicular size
- category: Endocrine
  frequency: FREQUENT
  name: Gynecomastia
  notes: Androgen/estrogen imbalance predisposes to breast tissue development
  phenotype_term:
    preferred_term: Gynecomastia
    term:
      id: HP:0000771
      label: Gynecomastia
- category: Metabolic
  frequency: OCCASIONAL
  name: Insulin Resistance
  notes: Increased risk of metabolic syndrome and type 2 diabetes
  phenotype_term:
    preferred_term: Insulin Resistance
    term:
      id: HP:0000855
      label: Insulin resistance
- category: Skeletal
  frequency: OCCASIONAL
  name: Osteopenia
  notes: Low testosterone and altered bone metabolism contribute to reduced bone density
  phenotype_term:
    preferred_term: Osteopenia
    term:
      id: HP:0000938
      label: Osteopenia
- category: Cardiovascular
  frequency: OCCASIONAL
  name: Increased Cardiovascular Risk
  notes: Elevated risk of cardiovascular disease related to hypogonadism and metabolic dysregulation
  phenotype_term:
    preferred_term: Abnormality of the Cardiovascular System
    term:
      id: HP:0001626
      label: Abnormality of the cardiovascular system
biochemical:
- name: Testosterone
  presence: Decreased
  context: Diagnostic for hypogonadism
  evidence:
  - reference: PMID:18504390
    supports: SUPPORT
    snippet: FSH and LH levels increase to hypergonadotropic levels, inhibin B decreases
      to undetectable levels, and testosterone after an initial increase levels off
      at a low or low-normal level.
    explanation: The literature indicates that testosterone levels in Klinefelter
      Syndrome patients become low or low-normal in adult males, which supports the
      diagnostic use of decreased testosterone for hypogonadism.
  - reference: PMID:29466784
    supports: SUPPORT
    snippet: FSH and LH levels in both NOA and KFS patients were significantly higher
      than the normal range, and the testosterone level in KFS patients was significantly
      lower.
    explanation: This study finds significantly lower testosterone levels in Klinefelter
      Syndrome patients, supporting the statement.
  - reference: PMID:28960039
    supports: SUPPORT
    snippet: Testosterone levels in patients belonging to the KS group were significantly
      lower compared to the control group (2.4 +/- 2.6 vs. 5.2 +/- 1.8 ng/mL, P &lt;
      0.001).
    explanation: The literature indicates that testosterone levels are significantly
      lower in Klinefelter Syndrome patients compared to controls, consistent with
      the statement.
  - reference: PMID:32567016
    supports: SUPPORT
    snippet: TRT in hypogonadal KS subjects was able to improve body composition and
      BMD at spinal levels but it was ineffective in ameliorating lipid and glycemic
      profile.
    explanation: Although focused on treatment, the literature supports the presence
      of low testosterone levels in Klinefelter Syndrome, thus supporting the diagnostic
      relevance for hypogonadism.
  - reference: PMID:34407199
    supports: SUPPORT
    snippet: Experimental studies on Klinefelter syndrome (KS) reported increased
      intratesticular testosterone (T) levels coexisting with reduced circulating
      levels.
    explanation: This supports the assertion of decreased peripheral or circulating
      testosterone levels in Klinefelter Syndrome, corroborating its diagnostic use
      for hypogonadism.
- name: FSH (Follicle-Stimulating Hormone)
  presence: Increased
  context: Indicative of gonadal dysfunction
  evidence:
  - reference: PMID:18504390
    supports: SUPPORT
    snippet: During childhood, and even during early puberty, pituitary-gonadal function
      in 47,XXY subjects is relatively normal, but from midpuberty onwards, FSH and
      LH levels increase to hypergonadotropic levels.
    explanation: The article describes that from midpuberty onwards, FSH levels increase
      to hypergonadotropic levels in Klinefelter syndrome, supporting the statement
      that increased FSH is indicative of gonadal dysfunction in KS.
  - reference: PMID:4583182
    supports: SUPPORT
    snippet: Primary gonadal failure characteristically resulted in exaggerated gonadotrophin
      response.
    explanation: This study indicates that primary gonadal failure, which is associated
      with gonadal dysfunction, results in an exaggerated response of gonadotropins
      such as FSH, supporting the statement about increased FSH in Klinefelter Syndrome.
  - reference: PMID:30914274
    supports: SUPPORT
    snippet: Single centre, cross-sectional study of 307 men with idiopathic infertility
      and 28 men with Klinefelter syndrome (KS)...The FSHR was expressed in the investigated
      human derived adipocytes, and 3-6 h treatment with FSH  markedly increased RANKL
      release (p &lt; .05).
    explanation: The article mentions that men with Klinefelter syndrome were part
      of the study, and elevated FSH levels were observed, indicating that high FSH
      is common in these men, thus supporting the statement.
genetic:
- name: 47,XXY Karyotype
  presence: Diagnostic
  evidence:
  - reference: PMID:34375016
    supports: SUPPORT
    snippet: Patients with Klinefelter syndrome (KS) show a typically 47,XXY karyotype;
      however, some variations have been observed, including 47,XX,der(Y), 46,XY/47,XXY,
      48,XXXY, 48,XXYY, and mosaicism or structural sex chromosome abnormalities in
      some patients.
    explanation: The study discusses that Klinefelter syndrome typically exhibits
      a 47,XXY karyotype.
  - reference: PMID:9160389
    supports: SUPPORT
    snippet: Cytogenetic surveys of neonates have found that approximately one boy
      in 500 is born with an extra sex chromosome. ... This study estimates what proportion
      of those not detected prenatally will be diagnosed postnatally and what the
      indications for karyotyping are likely to be.
    explanation: The study indicates that Klinefelter syndrome is associated with
      an extra sex chromosome, typically 47,XXY.
  - reference: PMID:31630146
    supports: SUPPORT
    snippet: Klinefelter syndrome (KS) is one of the most common congenital disorders
      of male infertility. Given its high heterogeneity in clinical and genetic presentation,
      the relationship between transcriptome, clinical phenotype, and associated co-morbidities
      seen in KS has not been fully clarified.
    explanation: This study identifies Klinefelter syndrome as a congenital disorder
      related to the 47,XXY karyotype.
  - reference: PMID:37054629
    supports: SUPPORT
    snippet: Klinefelter syndrome is the most frequently found aneuploidy among male
      patients. Its clinical presentation is very heterogeneous, and thus poses a
      challenge for a timely diagnosis.
    explanation: The study confirms that Klinefelter syndrome is an aneuploidy condition
      predominantly associated with the 47,XXY karyotype.
- name: KDM6A
  association: X-dosage escape gene
  notes: Escape from X-inactivation alters demethylase activity and chromatin regulation, contributing to dose-dependent transcriptional changes in tissues.
- name: SHOX
  association: Pseudoautosomal region gene
  notes: PAR1 gene with copy-number effects linked to tall stature phenotype due to gene dosage changes.
- name: TLR7
  association: X-dosage escape gene
  notes: Escape from X-inactivation produces increased innate immune signaling, contributing to heightened immune responses.
- name: AR
  association: Androgen signaling pathway
  notes: Androgen receptor dysfunction contributes to hypogonadism phenotype.
- name: INSL3
  association: Leydig cell function marker
  notes: INSL3 dynamics reflect Leydig cell health with age-dependent alterations in KS.
- name: Mosaicism (46,XY/47,XXY)
  presence: Occasional
  evidence:
  - reference: PMID:1176138
    supports: SUPPORT
    snippet: The percentage with mosaicism was 36 in both triple-X and Turner&#39;s syndrome,
      it was 7 and 11% in XYY and Klinefelter&#39;s syndrome, respectively...
    explanation: The reference discusses the occurrence of mosaicism in Klinefelter
      syndrome with a frequency of 11%, supporting that mosaicism is occasionally
      present in Klinefelter Syndrome.
  - reference: PMID:3490207
    supports: SUPPORT
    snippet: 46,XY/47,XXY mosaicism is not uncommon. However, mosaicism of multiple
      sex chromosome aneuploidy is rarely observed.
    explanation: This case report shows that 46,XY/47,XXY mosaicism is not uncommon
      in Klinefelter&#39;s syndrome, supporting the statement.
  - reference: PMID:5720649
    supports: SUPPORT
    snippet: Chromosomal mosaicism in two emotionally disturbed adolescents with Klinefelter&#39;s
      syndrome (46,XY-47,XXY and 46,XY-47,XYY-48,XXYY).
    explanation: The study mentions cases of mosaicism in Klinefelter&#39;s syndrome,
      providing support to the statement.
diagnosis:
- name: Karyotype Analysis
  presence: 47,XXY
  notes: Gold standard for confirming diagnosis
  evidence:
  - reference: PMID:9160389
    supports: SUPPORT
    snippet: This study suggests that most males born with these chromosome patterns
      will go through life without being karyotyped, ... that the commonest indication
      for a Klinefelter male to be karyotyped will be hypogonadism and/or infertility.
    explanation: This indicates that karyotype analysis is used to diagnose Klinefelter
      Syndrome, supporting the statement that karyotype analysis is the gold standard
      for confirming diagnosis.
  - reference: PMID:37054629
    supports: SUPPORT
    snippet: The karyotypes were identified using high resolution GTL banding at the
      Genetics Department.
    explanation: The mention of karyotype identification through high-resolution GTL
      banding supports the statement that karyotype analysis is used for diagnosing
      Klinefelter Syndrome.
  - reference: PMID:18668569
    supports: SUPPORT
    snippet: Sex chromosome genotyping was performed in 981 SLE patients...an overall
      rate of 47,XXY of 235 per 10,000 male SLE patients was found.
    explanation: The use of sex chromosome genotyping, a form of karyotype analysis,
      to identify 47,XXY patterns supports the statement that karyotype analysis is
      used for confirming the presence of Klinefelter Syndrome.
- name: Hormone Testing
  presence: Abnormal
  notes: Low testosterone and high FSH levels indicative
  evidence:
  - reference: PMID:22915094
    supports: SUPPORT
    snippet: The most important data for diagnosis are testicular volume, hormone
      levels and presence of azoospermia in spermiogram, especially in puberty and
      adult life.
    explanation: The study highlights hormone levels, including low testosterone and
      high FSH, as crucial for diagnosing Klinefelter Syndrome.
  - reference: PMID:30507702
    supports: SUPPORT
    snippet: Hypogonadism and testicular degeneration are almost universal. Truncal
      adiposity, metabolic syndrome, and low bone mass occur frequently.
    explanation: Mentions universal hypogonadism, which implies low testosterone,
      as a diagnostic feature of Klinefelter Syndrome.
  - reference: PMID:5083415
    supports: SUPPORT
    snippet: Pathologic testicular findings in Klinefelter&#39;s syndrome 47,XXY vs 46,XY-47,XXY.
    explanation: While this snippet doesn&#39;t provide specifics, the title suggests
      in-depth pathological features, likely supporting hormone-related findings.
  - reference: PMID:17766718
    supports: PARTIAL
    snippet: We found increased FSH/inhibin B ratio as a possible sign of Sertoli
      cell dysfunction. However, serum levels of T were high normal suggesting an
      altered pituitary-gonadal set point.
    explanation: This study finds high normal testosterone in infants, which could
      partially support the statement but does not represent adult KS diagnosis.
treatments:
- name: Testosterone Replacement Therapy
  description: Helps address symptoms of hypogonadism such as low energy, reduced
    muscle mass, and libido.
  evidence:
  - reference: PMID:35421871
    supports: SUPPORT
    snippet: Patients presenting with symptoms should be tested for low testosterone
      and treated with testosterone replacement. ... Patients treated for hypogonadism
      may experience improvement of symptoms and quality of life.
    explanation: This reference indicates that testosterone replacement therapy can
      improve symptoms associated with hypogonadism, such as low energy and reduced
      muscle mass.
  - reference: PMID:26732150
    supports: SUPPORT
    snippet: The mainstay of medical treatment is testosterone replacement therapy
      to both attenuate acute and long-term consequences of hypogonadism and possibly
      prevent the frequent comorbidity.
    explanation: This abstract highlights testosterone replacement therapy as a primary
      treatment for hypogonadism in Klinefelter Syndrome, addressing its symptoms.
  - reference: PMID:24142635
    supports: SUPPORT
    snippet: Testosterone replacement therapy may be effective in treating BMD deficiency
      in men with testosterone deficiency, especially those with Klinefelter syndrome.
    explanation: The study indicates the efficacy of testosterone replacement therapy
      in treating symptoms related to testosterone deficiency in Klinefelter syndrome,
      which implies improvements in overall physical health including muscle mass.
  - reference: PMID:38677872
    supports: PARTIAL
    snippet: Patients unable to produce sex steroids using gonadotropins to mimic
      minipuberty in hypogonadotropic hypogonadism, or sex steroids in patients with
      Klinefelter or Turner syndrome, is promising.
    explanation: This abstract discusses the potential of sex steroid treatments,
      including testosterone, but emphasizes the need for further research particularly
      in infants and early childhood.
  - reference: PMID:37962976
    supports: SUPPORT
    snippet: TRT in patients with KS has the potential for alleviating the prothrombotic
      phenotype, in particular by reducing body fat and fibrinogen.
    explanation: Testosterone replacement therapy has positive effects on symptoms
      related to body composition, which can be correlated to improvements in muscle
      mass and energy levels.
  treatment_term:
    preferred_term: hormone modifying therapy
    term:
      id: MAXO:0000283
      label: hormone modifying therapy
- name: Educational Support
  description: Special education services and speech therapy to improve language and
    academic skills.
  evidence:
  - reference: PMID:25899809
    supports: SUPPORT
    snippet: Boys with Klinefelter syndrome are often in the need of speech therapy
      and many suffer from learning disability and may benefit from special education.
    explanation: This article directly indicates the need for speech therapy and special
      education for boys with Klinefelter syndrome.
  - reference: PMID:35948402
    supports: SUPPORT
    snippet: Around two-thirds require speech and language therapy or developmental
      support and early institution of therapy is important.
    explanation: This article supports the statement by mentioning the necessity of
      speech and language therapy or developmental support.
  treatment_term:
    preferred_term: speech therapy
    term:
      id: MAXO:0000930
      label: speech therapy
- name: Fertility Treatment
  description: Assisted reproductive technologies such as testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) may help those who wish to have children.
  evidence:
  - reference: PMID:35667865
    supports: SUPPORT
    snippet: Assisted reproductive technology is essential for infertility treatment
      in patients with Klinefelter syndrome.
    explanation: This reference explicitly states the role of assisted reproductive
      technology in treating infertility in patients with Klinefelter syndrome.
  - reference: PMID:19490778
    supports: SUPPORT
    snippet: In conclusion, patients with non-mosaic Klinefelter syndrome have sperm
      recovery and pregnancy rates comparable with patients having non-obstructive
      azoospermia and normal karyotype.
    explanation: This study indicates that patients with Klinefelter syndrome can
      achieve successful sperm recovery and pregnancy rates using TESE-ICSI, a type
      of assisted reproductive technology.
  - reference: PMID:21835671
    supports: SUPPORT
    snippet: In this review, we will discuss the fertility issue following TEsticular
      Sperm Extraction-IntraCytoplasmic Sperm Injection (TESE-ICSI) and the potential
      advantage of searching for and cryopreserving spermatozoa in adolescent instead
      of adult patients.
    explanation: This reference discusses the advantages of using TESE-ICSI (a form
      of assisted reproductive technology) to address fertility issues in patients
      with Klinefelter syndrome.
  - reference: PMID:31587581
    supports: SUPPORT
    snippet: Once considered untreatable, men with KS and NOA now have a variety of
      treatment options to obtain paternity.
    explanation: This reference highlights that men with Klinefelter syndrome now
      have several treatment options, including assisted reproductive technologies,
      to achieve paternity.
  - reference: PMID:32562095
    supports: SUPPORT
    snippet: Mounting evidence from recent studies has shown that various technological
      advances and approaches could facilitate the success of ART treatment for KS
      patients.
    explanation: This review summarizes methods that enhance the success of assisted
      reproductive technology (ART) for patients with Klinefelter syndrome.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
- name: Psychological Support
  description: Counseling and psychological support to address social, emotional, and behavioral challenges.
  treatment_term:
    preferred_term: behavioral counseling
    term:
      id: MAXO:0000077
      label: behavioral counseling
- name: Multidisciplinary Care
  description: Comprehensive monitoring for metabolic, cardiovascular, and bone health complications.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
disease_term:
  preferred_term: Klinefelter syndrome
  term:
    id: MONDO:0006823
    label: Klinefelter syndrome
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Klinefelter_Syndrome.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>